Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling: Effective Familial OutReach Via Tele-genetics (EfFORT) Trial & Supporting Test Result Interpretation and Variant Education (STRIVE) Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05420064
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:59.093835+00:00
Published At
2025-11-12T00:00:00+00:00
Record Updated At
2025-11-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["BRCA1 Mutation", "POLD1 Gene Mutation", "CDKN2A Mutation", "BRCA2 Mutation", "POLE Gene Mutation", "APC Gene Mutation", "ATM Gene Mutation", "MLH1 Gene Mutation", "BARD1 Gene Mutation", "MSH2 Gene Mutation", "BRIP1 Gene Mutation", "MSH6 Gene Mutation", "CHEK2 Gene Mutation", "PMS2 Gene Mutation", "PALB2 Gene Mutation", "EPCAM Gene Mutation", "RAD51C Gene Mutation", "BMPR1A Gene Mutation", "RAD51D Gene Mutation", "SMAD4", "PTEN Gene Mutation", "GREM1"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-12"
protocolSection.identificationModule.nctId
"NCT05420064"
protocolSection.identificationModule.officialTitle
"Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling: Effective Familial OutReach Via Tele-genetics (EfFORT) Trial \u0026 Supporting Test Result Interpretation and Variant Education (STRIVE) Trial"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • BRCA1 Mutation (protocolSection.conditionsModule.conditions)
  • POLD1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • CDKN2A Mutation (protocolSection.conditionsModule.conditions)
  • BRCA2 Mutation (protocolSection.conditionsModule.conditions)
  • POLE Gene Mutation (protocolSection.conditionsModule.conditions)
  • APC Gene Mutation (protocolSection.conditionsModule.conditions)
  • ATM Gene Mutation (protocolSection.conditionsModule.conditions)
  • MLH1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • BARD1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • MSH2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • BRIP1 Gene Mutation (protocolSection.conditionsModule.conditions)
  • MSH6 Gene Mutation (protocolSection.conditionsModule.conditions)
  • CHEK2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • PMS2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • PALB2 Gene Mutation (protocolSection.conditionsModule.conditions)
  • EPCAM Gene Mutation (protocolSection.conditionsModule.conditions)
  • RAD51C Gene Mutation (protocolSection.conditionsModule.conditions)
  • BMPR1A Gene Mutation (protocolSection.conditionsModule.conditions)
  • RAD51D Gene Mutation (protocolSection.conditionsModule.conditions)
  • SMAD4 (protocolSection.conditionsModule.conditions)
  • PTEN Gene Mutation (protocolSection.conditionsModule.conditions)
  • GREM1 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.